MULTIPLE SCLEROSIS - THE GUIDE TO TREATMENT AND MANAGEMENT British Journal of Occupational TherapyJewell, Carol B
Multiple Sclerosis: The Guide for Treatment and Management, Fifth Edition : Chris H. Polman, Alan J. Thompson, J. Jock Murray, I. Ian McDonald. Demos Medical Publishing, New York, 2001, 148 pp., ISBN 1-888799-54-4, $24.95No abstract is available for this article....
Multiple Sclerosis Disease modifying treatment National guideline United Arab Emirates Middle East Gulf UAE 1. Introduction The United Arab Emirates (UAE) is home to about 10 million people, of which one million are Emirati citizens. UAE is considered a country with medium prevalence for Multiple ...
Stimulated by the successful introduction of interferon-β as treatment for relapsing-remitting multiple sclerosis (MS) and based on an improved knowledge of the immunopathology of MS, a vast array of treatment options is currently under investigation for disease course modification. These are targeting...
How much do multiple sclerosis treatments cost? Treating multiple sclerosis costs a great deal for patients and communities. Individually, the nearly 1 million people with MS pay an average annual cost of more than $88,000 for the various treatment options, devices, daily living needs, and insur...
Multiple Sclerosis: A Guide to Treatment and ManagementWriting a book in a quickly changing field becomes a difficult taskfor an author. Within the last decade, the basic concepts of many...
Optimizing outcomes in multiple sclerosis: consensus guidelines for the diagnosis and treatment of multiple sclerosis in Latin America A. Gabbai et al., "Optimizing outcomes in multiple sclerosis: consensus guidelines for the diagnosis and treatment of multiple sclerosis in Latin America,"... Adriana,...
Autologous haematopoietic stem cell transplantation (AHSCT) is a treatment option for some forms of multiple sclerosis (MS), but uncertainties remain about its implementation in clinical practice and treatment protocols need to be optimized. This Consensus Statement provides guidance and recommendations for...
Improvement of spasticity with dantrolene sodium in multiple sclerosis has been reliably reported to range from 30% to 40%.1 The results reported by Tolosa et al are in the same "ball park." The complexity of the mechanism of this disease is well known. Attainment of such results in 30% ...
摘要:Multiplesclerosisisthemostcommondisablingneurologicaldiseaseinyoungadults.Recentadvancesinunderstandingtheunderlyingmechanismsandthedevelopmentofnewtherapieshaveincreasedhopefordoctorsandtheirpatients.Newtherapiesareavailableandmanyotheragentsareun